1.
Sophie Voruz, Filipe Martins, Anne Cairoli, Olaia Naveiras, Krisztian Homicsko, Edoardo Missiaglia, Laurence de Leval, Bettina Bisig, Olivier Michielin, Sabine Blum. Comment on “MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma”. Haematologica 2018;103(3):e130-e130; https://doi.org/10.3324/haematol.2017.186932.